Holen Sie sich die Stockscreener-App
4.69
6.57%
-0.33
Handel nachbörslich:
4.78
0.09
+1.92%
Schlusskurs vom Vortag:
$5.02
Offen:
$5.1
24-Stunden-Volumen:
2.10M
Relative Volume:
0.83
Marktkapitalisierung:
$699.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-134.24M
KGV:
-2.6497
EPS:
-1.77
Netto-Cashflow:
$-121.34M
1W Leistung:
-8.22%
1M Leistung:
+15.52%
6M Leistung:
+66.90%
1J Leistung:
-14.73%
1-Tages-Spanne:
$4.65
$5.16
1-Wochen-Bereich:
$4.65
$5.18
52-Wochen-Spanne:
$1.285
$5.66
Annexon Inc Stock (ANNX) Company Profile
Firmenname
Annexon Inc
Sektor
Branche
Telefon
(650) 822-5500
Adresse
1400 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie ANNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.69 | 748.26M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-30 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-05-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-09-16 | Eingeleitet | Jefferies | Buy |
| 2022-09-09 | Eingeleitet | BTIG Research | Buy |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-26 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | BofA Securities | Buy |
| 2020-08-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Annexon Inc Aktie (ANNX) Neueste Nachrichten
Insider Buying: William Carson Acquires Additional Shares of Ann - GuruFocus
Insider Buying: Annexon (NASDAQ:ANNX) Director Purchases 4,115 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) Stock Price Down 6.9%Should You Sell? - MarketBeat
What analysts say about Annexon Inc stockMorning Star Patterns & Small Capital Investment Tips - earlytimes.in
Breakout Zone: Will Annexon Inc stock maintain growth story2025 Price Momentum & Growth Oriented Trading Recommendations - moha.gov.vn
Chardan Capital initiates coverage of Annexon (ANNX) with buy recommendation - MSN
Aug Macro: Will WAVE stock continue upward momentumExit Point & Risk Controlled Swing Trade Alerts - moha.gov.vn
Bollinger Bands Expand on Nahar Capital and Financial Services Limited Volatility AheadMerger & Acquisition Updates & Advanced Stock Screening Tools - earlytimes.in
Annexon (NASDAQ:ANNX) Upgraded at Chardan Capital - MarketBeat
Clear Street asserts buy rating on Annexon, Inc. (ANNX) amid progress on pipeline development - MSN
Chardan Capital Initiates Coverage on ANNX with a Buy Rating | A - GuruFocus
Chardan Initiates Annexon at Buy With $16 Price Target - marketscreener.com
Chardan Capital Markets initiates Annexon Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
Chardan Capital Markets initiates Annexon Biosciences stock with Buy rating - Investing.com
Annexon (ANNX) price target increased by 27.19% to 14.79 - MSN
Annexon, Inc.(NasdaqGS: ANNX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Annexon Inc.: New Coverage Initiates Buy Rating – Stock on the Rise - StocksToTrade
Is Annexon Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Risk Managed Investment Strategies - Улправда
Why Annexon Inc. stock is recommended by analystsJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
How resilient is Annexon Inc. stock in market downturnsOptions Play & Momentum Based Trading Signals - Улправда
Annexon Inc. Sees Promising Growth Following Insider Activity and Positive Clinical Results - StocksToTrade
Clear Street Boosts Annexon with Buy Rating Tied to Promising Study Results - timothysykes.com
Will Annexon Inc. stock benefit from AI adoptionM&A Rumor & Risk Adjusted Buy and Sell Alerts - Улправда
Is Annexon Inc. stock safe for conservative investorsJuly 2025 Closing Moves & High Accuracy Buy Signal Tips - Улправда
Annexon (NASDAQ:ANNX) Shares Up 9.6%Here's Why - MarketBeat
Is Annexon Inc. stock a buy on dipsInsider Buying & Community Verified Trade Signals - DonanımHaber
Quarterly Earnings: Is Annexon Inc. stock safe for conservative investors2025 Technical Patterns & Verified Swing Trading Watchlist - Улправда
Will Annexon Inc. stock maintain growth story2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Bölüm Sonu Canavarı
Clear Street Asserts Buy Rating on Annexon, Inc. (ANNX) amid Progress on Pipeline Development - Yahoo Finance
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Hold" by Analysts - MarketBeat
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech firm Annexon gives new hire 19,000 stock options in long-term deal - Stock Titan
3 High Growth Tech Stocks To Watch In The US Market - simplywall.st
With Annexon Up 14%, Insider Buyers Count Their Returns - Yahoo Finance
Sirios Capital Management L P Has $2.38 Million Stake in Annexon, Inc. $ANNX - MarketBeat
Annexon (NASDAQ:ANNX) Shares Up 6.2%Time to Buy? - MarketBeat
Independent Director of Annexon Jung Choi Buys More Stock - simplywall.st
Insider Buying: Annexon (NASDAQ:ANNX) Director Buys 4,115 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) Director Acquires $138,270.00 in Stock - MarketBeat
Finanzdaten der Annexon Inc-Aktie (ANNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):